Skip to main content
Journal cover image

A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.

Publication ,  Journal Article
Couture, J; Mitri, A; Lagace, R; Smits, R; Berk, T; Bouchard, HL; Fodde, R; Alman, B; Bapat, B
Published in: Clin Genet
March 2000

Desmoid tumors arise sporadically or as part of the extraintestinal manifestations of familial adenomatous polyposis (FAP). In FAP, two distinct clinical presentations of the desmoid phenotype are seen: 1) one or a few desmoid tumors present predominantly in the abdominal wall or the abdomen; 2) a florid proliferation of tumors early in life, mostly near the axial skeleton or extremities. These different phenotypes have been associated with different sites of germline mutations in the adenomatous polyposis coli gene (APC gene). We present a large, French-Canadian kindred with a florid desmoid tumor phenotype caused by a germline mutation at codon 2643-2644 of the APC gene. The phenotype was characterized by the early onset of multiple tumors, arising near the axial skeleton and in proximal extremities. The penetrance of desmoid tumors was near 100% in this kindred. However, the expression of the disease was variable amongst the different affected relatives. Many gene carriers had cutaneous cysts. Polyposis of the colon was rarely observed in the affected individuals and we did not document upper gastro-intestinal polyps. The mutant APC allele did not express a stable truncated protein in vivo. Molecular analysis of the proband's tumor DNA revealed a somatic inactivating mutation of the wild-type allele. Immunohistochemistry on the tumor also demonstrated elevated levels of beta-catenin. The present study demonstrates that this extreme 3' APC mutation is associated with a severely penetrant desmoid phenotype and attenuated polyposis coli. It also suggests the involvement of the beta-catenin pathway in the development of desmoid tumors in FAP. The natural history of the disease is variable between individuals, and surgical interventions have to be timed appropriately due to the frequent recurrences.

Duke Scholars

Published In

Clin Genet

DOI

ISSN

0009-9163

Publication Date

March 2000

Volume

57

Issue

3

Start / End Page

205 / 212

Location

Denmark

Related Subject Headings

  • beta Catenin
  • Trans-Activators
  • Skin Neoplasms
  • Phenotype
  • Pedigree
  • Molecular Sequence Data
  • Middle Aged
  • Male
  • Immunohistochemistry
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Couture, J., Mitri, A., Lagace, R., Smits, R., Berk, T., Bouchard, H. L., … Bapat, B. (2000). A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet, 57(3), 205–212. https://doi.org/10.1034/j.1399-0004.2000.570306.x
Couture, J., A. Mitri, R. Lagace, R. Smits, T. Berk, H. L. Bouchard, R. Fodde, B. Alman, and B. Bapat. “A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.Clin Genet 57, no. 3 (March 2000): 205–12. https://doi.org/10.1034/j.1399-0004.2000.570306.x.
Couture, J., et al. “A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.Clin Genet, vol. 57, no. 3, Mar. 2000, pp. 205–12. Pubmed, doi:10.1034/j.1399-0004.2000.570306.x.
Couture J, Mitri A, Lagace R, Smits R, Berk T, Bouchard HL, Fodde R, Alman B, Bapat B. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet. 2000 Mar;57(3):205–212.
Journal cover image

Published In

Clin Genet

DOI

ISSN

0009-9163

Publication Date

March 2000

Volume

57

Issue

3

Start / End Page

205 / 212

Location

Denmark

Related Subject Headings

  • beta Catenin
  • Trans-Activators
  • Skin Neoplasms
  • Phenotype
  • Pedigree
  • Molecular Sequence Data
  • Middle Aged
  • Male
  • Immunohistochemistry
  • Humans